- Home
- DSP vs AMRN Comparison
DSP vs AMRN Comparison
Compare DSP & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSP
- AMRN
- Stock Information
- Founded
- DSP 1999
- AMRN 1989
- Country
- DSP United States
- AMRN Ireland
- Employees
- DSP N/A
- AMRN N/A
- Industry
- DSP EDP Services
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- DSP Technology
- AMRN Health Care
- Exchange
- DSP Nasdaq
- AMRN Nasdaq
- Market Cap
- DSP 220.3M
- AMRN 216.0M
- IPO Year
- DSP 2021
- AMRN 1993
- Fundamental
- Price
- DSP $13.30
- AMRN $11.74
- Analyst Decision
- DSP Strong Buy
- AMRN Sell
- Analyst Count
- DSP 8
- AMRN 2
- Target Price
- DSP $21.75
- AMRN $7.00
- AVG Volume (30 Days)
- DSP 237.4K
- AMRN 75.4K
- Earning Date
- DSP 05-06-2025
- AMRN 05-07-2025
- Dividend Yield
- DSP N/A
- AMRN N/A
- EPS Growth
- DSP N/A
- AMRN N/A
- EPS
- DSP 0.13
- AMRN N/A
- Revenue
- DSP $306,484,000.00
- AMRN $214,112,000.00
- Revenue This Year
- DSP $19.27
- AMRN N/A
- Revenue Next Year
- DSP $14.55
- AMRN $5.97
- P/E Ratio
- DSP $102.54
- AMRN N/A
- Revenue Growth
- DSP 30.64
- AMRN N/A
- 52 Week Low
- DSP $8.70
- AMRN $7.08
- 52 Week High
- DSP $26.33
- AMRN $17.58
- Technical
- Relative Strength Index (RSI)
- DSP 41.56
- AMRN 66.86
- Support Level
- DSP $13.46
- AMRN $11.27
- Resistance Level
- DSP $14.72
- AMRN $11.84
- Average True Range (ATR)
- DSP 0.66
- AMRN 0.49
- MACD
- DSP -0.18
- AMRN 0.07
- Stochastic Oscillator
- DSP 2.32
- AMRN 84.21
About DSP Viant Technology Inc.
Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.